These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29451965)

  • 1. Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia.
    Parambil JG; Woodard TD; Koc ON
    Laryngoscope; 2018 Oct; 128(10):2234-2236. PubMed ID: 29451965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bevacizumab: a new success in hereditary hemorrhagic telangiectasia].
    Bennesser Alaoui H; Lehraiki M; Hamaz S; El Attar N; Fakhreddine N; Serraj K
    Rev Med Interne; 2015 Sep; 36(9):623-5. PubMed ID: 25595875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia.
    Kochanowski J; Sobieszczańska M; Tubek S; Żurek M; Pawełczak J
    Hum Vaccin Immunother; 2015; 11(3):680-1. PubMed ID: 25839219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron deficiency anemia related to hereditary hemorrhagic telangiectasia: response to treatment with bevacizumab.
    Fleagle JM; Bobba RK; Kardinal CG; Freter CE
    Am J Med Sci; 2012 Mar; 343(3):249-51. PubMed ID: 22227516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia.
    Parambil JG; Gossage JR; McCrae KR; Woodard TD; Menon KVN; Timmerman KL; Pederson DP; Sprecher DL; Al-Samkari H
    Angiogenesis; 2022 Feb; 25(1):87-97. PubMed ID: 34292451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab as Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Literature Review.
    Kini SD; Yiu DW; Weisberg RA; Davila JF; Chelius DC
    Ann Otol Rhinol Laryngol; 2019 May; 128(5):467-471. PubMed ID: 30693788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.
    Huemer F; Dejaco M; Grabmer C; Melchardt T; Neureiter D; Mayer G; Egle A; Greil R; Weiss L
    Wien Klin Wochenschr; 2017 Feb; 129(3-4):141-144. PubMed ID: 27878613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary hemorrhagic telangiectasia/avastin.
    Davidson TM; Olitsky SE; Wei JL
    Laryngoscope; 2010 Feb; 120(2):432-5. PubMed ID: 19998344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term experience with intranasal bevacizumab therapy.
    Steineger J; Osnes T; Heimdal K; Dheyauldeen S
    Laryngoscope; 2018 Oct; 128(10):2237-2244. PubMed ID: 29469958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress of bevacizumab in the treatment of refractory epistaxis caused by hereditary hemorrhagic telangiectasia].
    Xu C; Wang HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 51(6):476-9. PubMed ID: 27345893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous bevacizumab for complications of hereditary hemorrhagic telangiectasia: a review of the literature.
    Arizmendez NP; Rudmik L; Poetker DM
    Int Forum Allergy Rhinol; 2015 Nov; 5(11):1042-7. PubMed ID: 26202958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia: An Evidence-based Review.
    Halderman AA; Ryan MW; Marple BF; Sindwani R; Reh DD; Poetker DM
    Am J Rhinol Allergy; 2018 Jul; 32(4):258-268. PubMed ID: 29745243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection of bevacizumab and cyanoacrylate glue for hereditary hemorrhagic telangiectasia.
    Khoueir N; Borsik M; Camous D; Herman P; Verillaud B
    Laryngoscope; 2019 Oct; 129(10):2210-2215. PubMed ID: 31566760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Iron deficiency anemia in a patient with hereditary hemorrhagic telangiectasia. Case report].
    Mozdon MA; Ponomarev RV; Tsvetaeva NV; Shabrin AV; Ermachenkova EI; Larichev SE; Lukina EA
    Ter Arkh; 2023 Sep; 95(7):580-585. PubMed ID: 38159009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia.
    Al-Samkari H; Kritharis A; Rodriguez-Lopez JM; Kuter DJ
    J Intern Med; 2019 Feb; 285(2):223-231. PubMed ID: 30191646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blessing for the bleeder: bevacizumab in hereditary hemorrhagic telangiectasia.
    Epperla N; Hocking W
    Clin Med Res; 2015 Mar; 13(1):32-5. PubMed ID: 24667223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia-Related Epistaxis and Gastrointestinal Bleeding.
    Iyer VN; Apala DR; Pannu BS; Kotecha A; Brinjikji W; Leise MD; Kamath PS; Misra S; Begna KH; Cartin-Ceba R; DuBrock HM; Krowka MJ; O'Brien EK; Pruthi RK; Schroeder DR; Swanson KL
    Mayo Clin Proc; 2018 Feb; 93(2):155-166. PubMed ID: 29395350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
    Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
    Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.
    Dupuis-Girod S; Ginon I; Saurin JC; Marion D; Guillot E; Decullier E; Roux A; Carette MF; Gilbert-Dussardier B; Hatron PY; Lacombe P; Lorcerie B; Rivière S; Corre R; Giraud S; Bailly S; Paintaud G; Ternant D; Valette PJ; Plauchu H; Faure F
    JAMA; 2012 Mar; 307(9):948-55. PubMed ID: 22396517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, controlled, double-blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization.
    Khanwalkar AR; Rathor A; Read AK; Paknezhad H; Ma Y; Hwang PH
    Int Forum Allergy Rhinol; 2022 Aug; 12(8):1034-1042. PubMed ID: 34989143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.